Interns continue to make tough choices

Published Date: 02 Mar 2023

The Medscape Ethics Survey investigated how internal medicine physicians view the ethical aspects of the response to medical assistance in dying, gender-related publications and materials.

Read Full News

Latest News

Adult With Established RA and Symptoms of ILD/PPF

A 50-year-old man with rheumatoid arthritis and symptoms of interstitial lung disease or progressive pulmonary fibrosis is evaluated by experts. Treatment options and care priorities are discussed.

S4 Episode 3: How Much Monitoring Is Enough in Psoriasis Care?

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

The Half-Life of Medical Certainty

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

Infographic: How Much a Doctor’s Average Pay in the US Rose

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Man With Spinal Compression From Hepatocellular Carcinoma

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Todays Updates

AstraZeneca to Invest $405 Million in Britain After US-UK Pharma Deal

Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 ⁠million) in the country, after pausing...

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inhibitor adalimumab.

AAN 2026: Key RRMS Clinical Trial Updates

Dr Chu-Yueh Guo discusses promising MS trial results, including a study of fenebrutinib and positive safety data for ocrelizumab in pregnancy and pediatric patients.

Are Smartwatches Changing Arrhythmia Care?

Wearables can flag AF and capture symptoms in real time — but who truly benefits? Cardiologist Walid Amara, MD, outlines where smartwatches fit in clinical practice.

Why the FDA Rejected RP-1 in Melanoma: A Data Deep Dive

Dr Bishal Gyawali unpacks the FDA’s decision to deny RP-1 in melanoma, exploring why single-arm data and confounded response rates failed to meet the bar for clinical evidence.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

‘Living’ Database Tracks Psilocybin Trials for Depression

Sypres.io continuously tracks and evaluates psychedelic research, offering an up-to date view of study findings, design, and limitations.

Latest News

A 50-year-old man with rheumatoid arthritis and symptoms of interstitial lung disease or progressive pulmonary fibrosis is evaluated by experts. Treatment options and care priorities are discussed.

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

News All Time

S1 Episode 2: Can Early Genetic Testing Change ATTR-CM Outcomes?

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

S1 Episode 1: Rethinking Rhythm Control in ATTR-CM

Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

Chest Plaque Reveals Dermatofibrosarcoma in a Man

Dermatofibrosarcoma protuberans can masquerade as a benign plaque — this case requires biopsy of a 10 × 8 cm anterior chest lesion to confirm spindle cell sarcoma and guide curative surgical excision.

New ‘Breathing’ Lung-On-Chip Surprises Against Tuberculosis

Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and inhibits tuberculosis growth.

S2 Episode 6: PCR in Breast Cancer and HER2

Drs Kathy Miller and Lajos Pusztai discuss predicting which patients will have a PCR, and the impact this has on new treatments or reducing the intensity of treatments.

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Stress Doesn’t Cause Cancer

The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.

Insights in Renal Cell Carcinoma From ASCO GU 2026

Clinically significant developments in RCC presented at ASCO GU, including insights into the growing importance of HIF-2α inhibition, are discussed by Dr Brian Rini of Vanderbilt University.

Mar 20 2026 This Week in Cardiology

Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the controversial ACC/AHA lipid treatment guidelines are the topics John Mandrola, MD, discusses in this week's podcast.

Quantifying Cardiac Amyloid Burden

A standardized metric to quantify amyloid burden has yet to be established. Could extracellular volume assessments help track ATTR-CM disease status.

A 2-Year-Old Girl With a Single Pink “Bump” on Her Abdomen

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, rapid growth, or preceding trauma.

Rules for Thee, Not for Me: Neuroscience & Double Standards

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Recommended News For You

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

Year in Review: Chronic Lymphocytic Leukemia

Recommended Articles For You

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation 

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025 

The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery 

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

3.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

4.

Emicizumab in Infants With Hemophilia A: Safe and Effective Use.

5.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

1.

Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings

2.

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers

3.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

4.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

5.

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

5.

Should We Use DARA Up Front As First-Line Therapy in MM?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot